Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Geoffrey J, Clark"'
Autor:
Dominique Z. Jones, M. Lee Schmidt, Suman Suman, Katharine R. Hobbing, Shirish S. Barve, Leila Gobejishvili, Guy Brock, Carolyn M. Klinge, Shesh N. Rai, Jong Park, Geoffrey J. Clark, Rajesh Agarwal, LaCreis R. Kidd
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-16 (2018)
Abstract Background Dysregulation of microRNA (miRNA) expression is associated with hallmarks of aggressive tumor phenotypes, e.g., enhanced cell growth, proliferation, invasion, and anchorage independent growth in prostate cancer (PCa). Methods Seru
Externí odkaz:
https://doaj.org/article/bfc4991aa79b45b7bd513dceb81c33ea
Autor:
Geoffrey J. Clark, Virna Leaner, Laura Gordon, Michael J. Birrer, Michele D. Vos, Howard Donninger, Diego F. Calvisi
Supplementary Figure 2 from NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0af5165d1da81515456ea0dca45b69
https://doi.org/10.1158/0008-5472.22378629
https://doi.org/10.1158/0008-5472.22378629
Autor:
Geoffrey J. Clark, Virna Leaner, Laura Gordon, Michael J. Birrer, Michele D. Vos, Howard Donninger, Diego F. Calvisi
Supplementary Figure and Table Legends 1-2 from NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c0a64aa4ff453fc908a8e811c60df1
https://doi.org/10.1158/0008-5472.22378626.v1
https://doi.org/10.1158/0008-5472.22378626.v1
Autor:
Geoffrey J. Clark, Virna Leaner, Laura Gordon, Michael J. Birrer, Michele D. Vos, Howard Donninger, Diego F. Calvisi
Supplementary Table 2 from NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad5152c2356f503a7b7fdbf0b9a08edf
https://doi.org/10.1158/0008-5472.22378620
https://doi.org/10.1158/0008-5472.22378620
Autor:
Geoffrey J. Clark, Virna Leaner, Laura Gordon, Michael J. Birrer, Michele D. Vos, Howard Donninger, Diego F. Calvisi
Supplementary Figure 1 from NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac3a64f4da03444936525b07b99fb82
https://doi.org/10.1158/0008-5472.22378632.v1
https://doi.org/10.1158/0008-5472.22378632.v1
Autor:
Geoffrey J. Clark, Virna Leaner, Laura Gordon, Michael J. Birrer, Michele D. Vos, Howard Donninger, Diego F. Calvisi
Supplementary Table 1 from NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e9afd77089c548c3d48f60cbaa5349
https://doi.org/10.1158/0008-5472.22378623
https://doi.org/10.1158/0008-5472.22378623
Autor:
Howard Donninger, Geoffrey J. Clark
Publikováno v:
Tumor Suppressor Par-4 ISBN: 9783030735715
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12c68be5eb6f1ba8c95c11265bfb3084
https://doi.org/10.1007/978-3-030-73572-2_9
https://doi.org/10.1007/978-3-030-73572-2_9
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2262
RASSF1A is a Ras effector that promotes the anti-proliferative properties of Ras. It acts as a scaffold protein that regulates several pro-apoptotic signaling pathways, thereby linking Ras to their regulation. However, accumulating evidence suggests
Publikováno v:
Methods in Molecular Biology ISBN: 9781071611890
RASSF1A is a Ras effector that promotes the anti-proliferative properties of Ras. It acts as a scaffold protein that regulates several pro-apoptotic signaling pathways, thereby linking Ras to their regulation. However, accumulating evidence suggests
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6429d979f16ce17eeb2b7fff8b3cf40
https://doi.org/10.1007/978-1-0716-1190-6_18
https://doi.org/10.1007/978-1-0716-1190-6_18
Publikováno v:
Cancers
Cancers, Vol 12, Iss 3807, p 3807 (2020)
Volume 12
Issue 12
Cancers, Vol 12, Iss 3807, p 3807 (2020)
Volume 12
Issue 12
Simple Summary The RASSF1A tumor suppressor can serve as a pro-apoptotic effector of the K-RAS oncoprotein. It is frequently inactivated epigenetically in lung cancer, and genetic inactivation of RASSF1A in transgenic mice enhances the ability of mut